12-55637042-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_206899.1(OR10P1):c.151G>A(p.Val51Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000582 in 1,613,842 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_206899.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR10P1 | NM_206899.1 | c.151G>A | p.Val51Ile | missense_variant | 1/1 | ENST00000309675.3 | NP_996782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR10P1 | ENST00000309675.3 | c.151G>A | p.Val51Ile | missense_variant | 1/1 | 6 | NM_206899.1 | ENSP00000308082.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151954Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251478Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135910
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461888Hom.: 2 Cov.: 32 AF XY: 0.0000701 AC XY: 51AN XY: 727246
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151954Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74222
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2024 | The c.151G>A (p.V51I) alteration is located in exon 1 (coding exon 1) of the OR10P1 gene. This alteration results from a G to A substitution at nucleotide position 151, causing the valine (V) at amino acid position 51 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at